review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/0741-8329(93)90063-T |
P698 | PubMed publication ID | 8123198 |
P50 | author | Erik Eliasson | Q42530438 |
Emanuele Albano | Q57720366 | ||
P2093 | author name string | M Ingelman-Sundberg | |
H Yin | |||
I Johansson | |||
P Clot | |||
Y Terelius | |||
P433 | issue | 6 | |
P304 | page(s) | 447-452 | |
P577 | publication date | 1993-11-01 | |
P1433 | published in | Alcohol | Q15724430 |
P1476 | title | Ethanol-inducible cytochrome P4502E1: genetic polymorphism, regulation, and possible role in the etiology of alcohol-induced liver disease | |
P478 | volume | 10 |
Q57302808 | 3 The pharmacology of the cytochrome P450 enzyme system |
Q46048455 | A haplotype analysis of CYP2E1 polymorphisms in relation to alcoholic phenotypes in Mexican Americans |
Q40920371 | A soluble NH(2)-terminally truncated catalytically active form of rat cytochrome P450 2E1 targeted to liver mitochondria(1). |
Q44233478 | Alcoholic liver injury and apoptosis--synopsis of the symposium held at ESBRA 2001: 8th Congress of the European Society for Biomedical Research on Alcoholism, Paris, September 16, 2001. |
Q51523474 | An investigation of cytochrome p450 (CYP) and glutathione S-transferase (GST) isoenzyme protein expression and related interactions with phototherapy in patients with psoriasis vulgaris. |
Q34116666 | Aquaporin-4 knockout enhances astrocyte toxicity induced by 1-methyl-4-phenylpyridinium ion and lipopolysaccharide via increasing the expression of cytochrome P4502E1. |
Q43775833 | CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people |
Q38418677 | CYP2E1 PstI/RsaI polymorphism and interaction with alcohol consumption in hepatocellular carcinoma susceptibility: evidence from 1,661 cases and 2,317 controls |
Q64898654 | CYP2E1 and CYP3A1/2 gene expression is not associated with the ursodeoxycholate effect on ethanol-induced lipoperoxidation. |
Q73635116 | CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan |
Q46886032 | Carcinogenetic impact of ADH1B and ALDH2 genes on squamous cell carcinoma risk of the esophagus with regard to the consumption of alcohol, tobacco and betel quid |
Q38008699 | Choline deprivation: an overview of the major hepatic metabolic response pathways |
Q44341681 | Cinnamic compound metabolism in human skin and the role metabolism may play in determining relative sensitisation potency |
Q46067848 | Cytochrome P450 2E1 and head and neck cancer: interaction with genetic and environmental risk factors |
Q47182200 | Cytochrome P4502E1 genotypes, alcoholism, and alcoholic cirrhosis in Han Chinese and Atayal Natives of Taiwan |
Q57550414 | Determination of chlorzoxazone and 6-hydroxychlorzoxazone in plasma by gas chromatography–mass spectrometry |
Q77619522 | Dietary carbohydrate intake plays an important role in preventing alcoholic fatty liver in the rat |
Q47965928 | Different dosages of acetylsalicylic acid lead to adverse modifications of the reaction of rat pancreas to ethanol |
Q77910649 | Differential induction of rat hepatic microsomal epoxide hydrolase and rGSTA2 by diazines: the role of cytochrome P450 2E1-mediated metabolic activation |
Q53622513 | Effect of chronic dietary ethanol in the promotion of N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in rats. |
Q47986521 | Effect of ethanol administration on the level of dolichol in rat liver microsomes and Golgi apparatus |
Q34315186 | Effects of SNPs (CYP1B1*2 G355T, CYP1B1*3 C4326G, and CYP2E1*5 G-1293C), smoking, and drinking on susceptibility to laryngeal cancer among Han Chinese |
Q44361860 | Enhancing risk of ethanol on MeIQx-induced rat hepatocarcinogenesis is accompanied with increased levels of cellular proliferation and oxidative stress |
Q73447652 | Ethanol downregulates transcription of the PAI-1 gene in cultured human endothelial cells |
Q43686104 | Ethanol enhances the formation of endogenously and exogenously derived adducts in rat hepatic DNA. |
Q38687958 | Ethanol metabolism, toxicity and genetic polymorphism |
Q47861259 | Ethanol transcriptionally upregulates t-PA and u-PA gene expression in cultured human endothelial cells |
Q32117371 | Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells |
Q43707092 | Examination of a CYP2E1 repeat polymorphism in a monkey model of alcohol abuse |
Q48558516 | Expression of constitutive and inducible cytochrome P450 2E1 in rat brain |
Q43680878 | Gender difference in enzymes related with alcohol consumption in hamster, an avid consumer of alcohol |
Q38824701 | Gene copy number variation analysis reveals dosage-insensitive expression of CYP2E1. |
Q32117706 | Genetic determinants of alcohol addiction and metabolism: a survey in Italy |
Q47643728 | Genetic polymorphism analysis of cytochrome P4502E1 (CYP2E1) in a Chinese Tibetan population |
Q37698409 | Genetic polymorphism in CYP2E1: Population distribution of CYP2E1 activity |
Q43735186 | Genetic polymorphism of cytochrome P450 2E1 in the Turkish population |
Q71497772 | Genetic polymorphism of human cytochrome P450 2E1 |
Q33918450 | Genetic polymorphisms of cytochrome p4502E1 and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a white population: a study and literature review, including meta-analysis. |
Q43643581 | Genetic repeat polymorphism in the regulating region of CYP2E1: frequency and relationship with enzymatic activity in alcoholics |
Q40648076 | Glucose inhibition of the induction of CYP2E1 mRNA expression by ethanol in FGC-4 cells |
Q35327402 | Gut microbiome and nonalcoholic fatty liver diseases |
Q74027130 | Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis |
Q74184908 | How does the body deal with energy from alcohol? |
Q40832491 | Identification and characterization of a mitochondrial targeting signal in rat cytochrome P450 2E1 (CYP2E1). |
Q43616528 | Identification of a 251-bp fragment of the PAI-1 gene promoter that mediates the ethanol-induced suppression of PAI-1 expression |
Q72294030 | Immunohistochemical localization of cytochrome P450 2E1 in human pulmonary carcinoma and normal bronchial tissue |
Q91816495 | In Vivo Hepatoprotective Effects of a Peptide Fraction from Krill Protein Hydrolysates against Alcohol-Induced Oxidative Damage |
Q44637720 | In vivo monitoring of hepatic oxygenation changes in chronically ethanol‐treated rats by functional magnetic resonance imaging |
Q40909505 | Inducers of cytochrome P450 2E1 enhance methotrexate-induced hepatocytoxicity |
Q51587174 | Induction mechanisms of cytochrome P450 2E1 in liver: Interplay between ethanol treatment and starvation |
Q36372912 | Induction of CYP2E1 in non-alcoholic fatty liver diseases |
Q44094041 | Influence of chronic ethanol consumption on toxic effects of 1,2-dichloroethane: glycolipoprotein retention and impairment of dolichol concentration in rat liver microsomes and Golgi apparatus |
Q41249900 | Influence of ethanol on in vitro growth of human mammary carcinoma cell line MCF-7. |
Q51446446 | Influence of urethane and ketamine on rat hepatic cytochrome P450 in vivo. |
Q47722066 | Inhibition of CYP2E1 by chlormethiazole as measured by chlorzoxazone pharmacokinetics in patients with alcoholism and in healthy volunteers |
Q42550847 | Inhibition of cytochrome P450 2E1 expression by 2-(allylthio)pyrazine, a potential chemoprotective agent: hepatoprotective effects |
Q74012586 | Kupffer cell inactivation alleviates ethanol-induced steatosis and CYP2E1 induction but not inflammatory responses in rat liver |
Q28382981 | Laboratory models available to study alcohol-induced organ damage and immune variations: choosing the appropriate model |
Q77409352 | Liver nuclear ethanol metabolizing systems (NEMS) producing acetaldehyde and 1-hydroxyethyl free radicals |
Q43553305 | Lymphocyte cytochrome P450-CYP2E1 expression in human IDDM subjects |
Q72282193 | Modulation of experimental alcohol-induced liver disease by cytochrome P450 2E1 inhibitors |
Q57371875 | Molecular Basis for the Transport of Cytochrome P450 2E1 to the Plasma Membrane |
Q41046037 | Molecular and genetic aspects of ethanol in human diet: a nutrient or a toxicant? |
Q36832562 | NOX in liver fibrosis |
Q40335692 | Overexpression of CYP2E1 in mitochondria sensitizes HepG2 cells to the toxicity caused by depletion of glutathione |
Q73208604 | Phase I and phase II drug-metabolizing enzymes are expressed and heterogeneously distributed in the biliary epithelium |
Q44252918 | Phenotype distribution and gender-related differences of CYP2E1 activity in a Chinese population |
Q43967442 | Polymorphism in alcohol-metabolizing enzymes, glutathione S-transferases and apolipoprotein E and susceptibility to alcohol-induced cirrhosis and chronic pancreatitis |
Q73332856 | Polymorphism in the cytochrome P450 2E1 gene and the risk of alcoholic liver disease |
Q36376313 | Polymorphism of Alcohol Metabolizing Gene ADH3 Predisposes to Development of Alcoholic Pancreatitis in North Indian Population |
Q47899895 | Role of cytokines in ethanol-induced cytotoxicity in vitro in Hep G2 cells |
Q52843675 | Roles of CYP2e1 in 1,2-dichloroethane-induced liver damage in mice. |
Q34555838 | Roles of cytochrome P4502E1 gene polymorphisms and the risks of alcoholic liver disease: a meta-analysis |
Q37517351 | RsaI but not DraI polymorphism in CYP2E1 gene increases the risk of gastrointestinal cancer in Malaysians: a case-control study |
Q34410274 | RsaI polymorphism at the cytochrome P4502E1 locus and risk of hepatocellular carcinoma |
Q40799272 | Signaling for ethanol-induced apoptosis and repair in vitro |
Q43593962 | Study of polymorphisms in the CYP2E1 gene in patients with alcoholic pancreatitis |
Q40719876 | Synergetic signaling for apoptosis in vitro by ethanol and acetaminophen |
Q28481380 | Systematic functional characterization of cytochrome P450 2E1 promoter variants in the Chinese Han population |
Q44413777 | The ADH3*2 and CYP2E1 c2 alleles increase the risk of alcoholism in Mexican American men |
Q33726099 | The PstI/RsaI and DraI polymorphisms of CYP2E1 and head and neck cancer risk: a meta-analysis based on 21 case-control studies. |
Q31386626 | The effects of the ALDH2*1/2, CYP2E1 C1/C2 and C/D genotypes on blood ethanol elimination |
Q37835918 | The impact of CYP2E1 genetic variability on risk assessment of VOC mixtures |
Q41401684 | The metabolism of psychoactive drugs: a review of enzymatic biotransformation and inhibition |
Q40418751 | The use of in vitro metabolism techniques in the planning and interpretation of drug safety studies |
Search more.